Related Articles
Matrix metalloproteinase‑2 and ‑9 and tissue inhibitor of metalloproteinase‑1 and ‑2 in sera and urine of patients with renal carcinoma
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase‑9 (MMP‑9) and their complex MMP‑9/NGAL in sera and urine of patients with kidney tumors
Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients